Altimmune, Inc.
ALT · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 11, 2026 | — | 1.75K | — | -0.15 | — |
| 2026 Q1 | May 13, 2026 | — | 1.43K | -0.18 | -0.25 | -1.95% |
| 2025 Q4 | March 5, 2026 | 26.00K | 556.00 | -0.27 | -0.25 | -17.92% |
| 2025 Q3 | November 6, 2025 | 5.00K | 560.00 | -0.21 | -0.29 | +5.07% |
| 2025 Q2 | August 12, 2025 | 5.00K | 1.43K | -0.27 | -0.32 | +7.10% |
| 2025 Q1 | May 13, 2025 | 5.00K | 560.00 | -0.26 | -0.35 | -4.16% |
| 2024 Q4 | February 27, 2025 | 5.00K | 1.00K | -0.33 | -0.34 | +8.08% |
| 2024 Q3 | November 12, 2024 | 5.00K | 714.00 | -0.32 | -0.36 | +29.12% |
| 2024 Q2 | August 8, 2024 | 5.00K | 714.00 | -0.35 | -0.34 | +15.09% |
| 2024 Q1 | May 9, 2024 | 5.00K | — | -0.34 | -0.36 | +7.82% |
| 2023 Q4 | March 27, 2024 | 37.00K | 2.14K | -0.33 | -0.35 | +2.77% |
| 2023 Q3 | November 7, 2023 | 362.00K | 857.00 | -0.39 | -0.40 | +1.12% |
| 2023 Q2 | August 10, 2023 | 6.00K | 3.00K | -0.32 | -0.44 | +3.05% |
| 2023 Q1 | May 11, 2023 | 21.00K | — | -0.40 | -0.49 | +7.03% |
| 2022 Q4 | February 28, 2023 | 110.00K | 28.86K | -0.43 | -0.52 | +6.42% |
| 2022 Q3 | November 10, 2022 | 2.00K | 867.83K | -0.48 | -0.49 | +9.18% |